The utility of the Helicobacter pylori stool antigen test in managing dyspepsia: an experience from a low resource setting
- PMID: 25834490
- PMCID: PMC4370061
- DOI: 10.4314/ahs.v14i4.9
The utility of the Helicobacter pylori stool antigen test in managing dyspepsia: an experience from a low resource setting
Abstract
Background: Dyspepsia is defined as a chronic or recurrent pain or discomfort centered in the upper abdomen. Endoscopy is the best strategy for confirming the cause of dyspepsia. Non- invasive strategies would be more appropriate in low resource countries where endoscopy is not readily available. However, there is concern that these strategies may miss serious disease like gastric cancer. One test that needs to be assessed in this regard is the Helicobacter pylori stool antigen test (HPSAT).
Objective: To determine the validity of the stool antigen test in predicting H. pylori associated disease among patients with dyspepsia.
Methods: In this prospective study patients with dyspepsia attending Mulago Hospital were recruited consecutively. Helicobacter pylori was determined using the Rapid Strip HpSA ®, endoscopy and gastric mucosal biopsy were done.
Results: 167 patients with dyspepsia were recruited into the study. There were ninety six (57.5%) females and seventy one (42.5%) males with an average age of 48.1(±18.1) years. Patients presenting with dyspepsia in Mulago hospital were more likely to come from the Central 60 (36%) and western tribes 55 (33%). The commonest endoscopic finding was oesophagitis 25 (15%). Peptic ulcer disease was found in 32 (19.2%) and 54 (32.3%) had normal endoscopy findings. H pylori was found in 33.5% and 32.5% using the HPSAT and histology respectively. The validity of the HPSAT in predicting H.pylori associated diseases was generally low with an overall sensitivity of 55.8%, and specificity of 74.2%. However, the validity was higher in predicting the diagnosis of peptic ulcer disease with a sensitivity 59.4% and specificity 72.6%.
Conclusion and recommendations: The HPSAT may be used in the test and treat strategy for young patients with dyspepsia without alarm signs and symptoms in low resource settings. However, because of its low validity in predicting H.pylori associated disease, it is important to follow up patients so that if symptoms persist or recur endoscopy is performed.
Keywords: dyspepsia; helicobacter pylori; low resource setting; stool antigen.
Similar articles
-
Comparison of helicobacter pylori stool antigen test with CLO test in the diagnosis of helicobacter pylori associated dyspepsia in a Saudi population.Saudi Med J. 2004 Dec;25(12):1906-8. Saudi Med J. 2004. PMID: 15711664
-
Evaluation of a new enzyme immunoassay for the detection of Helicobacter pylori in stool specimens.J Egypt Soc Parasitol. 2003 Dec;33(3):905-15. J Egypt Soc Parasitol. 2003. PMID: 14708861
-
Comparison of two different stool antigen tests for the primary diagnosis of Helicobacter pylori infection in turkish patients with dyspepsia.Helicobacter. 2004 Dec;9(6):657-62. doi: 10.1111/j.1083-4389.2004.00280.x. Helicobacter. 2004. PMID: 15610080 Clinical Trial.
-
[Helicobacter pylori stool antigen test].Nihon Rinsho. 2004 Mar;62(3):464-9. Nihon Rinsho. 2004. PMID: 15038088 Review. Japanese.
-
Should non-invasive Helicobacter pylori testing replace endoscopy in investigation of dyspepsia?Helicobacter. 2000;5 Suppl 1:S11-5; discussion S27-31. doi: 10.1046/j.1523-5378.2000.0050s1011.x. Helicobacter. 2000. PMID: 10828749 Review.
Cited by
-
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.BMC Gastroenterol. 2018 Aug 30;18(1):134. doi: 10.1186/s12876-018-0863-2. BMC Gastroenterol. 2018. PMID: 30165823 Free PMC article. Clinical Trial.
-
Diagnostic performance of fecal Helicobacter pylori antigen test in Uganda.BMC Gastroenterol. 2022 Dec 14;22(1):518. doi: 10.1186/s12876-022-02551-z. BMC Gastroenterol. 2022. PMID: 36513969 Free PMC article.
-
The Evaluation of Diagnostic and Predictive Values of Helicobacter pylori Stool Antigen Test in Iranian Patients with Dyspepsia.Iran J Pathol. 2018 Winter;13(1):38-44. Iran J Pathol. 2018. PMID: 29731794 Free PMC article.
-
The Probiotic Lactobacillus rhamnosus for Alleviation of Helicobacter pylori-Associated Gastric Pathology in East Africa.Front Microbiol. 2018 Aug 14;9:1873. doi: 10.3389/fmicb.2018.01873. eCollection 2018. Front Microbiol. 2018. PMID: 30154777 Free PMC article. Review.
-
Community prevalence of Helicobacter pylori and dyspepsia and efficacy of triple therapy in a rural district of eastern Uganda.Heliyon. 2022 Dec 23;8(12):e12612. doi: 10.1016/j.heliyon.2022.e12612. eCollection 2022 Dec. Heliyon. 2022. PMID: 36593846 Free PMC article.
References
-
- Talley NJ, Vakil N. Guidelines for the Management of Dyspepsia. Am J Gastroenterol. 2005;100(10):2324–2337. - PubMed
-
- Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther. 2003;17(12):1481–1491. - PubMed
-
- Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut. 2012;61(5):646–664. - PubMed
-
- Kagimu M, Winkler C, Ddumba E. Who should be screened to reduce the endoscopy workload in Mulago Hospital? East Afr Med J. 1996;73(12):832–834. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical